<code id='1697904736'></code><style id='1697904736'></style>
    • <acronym id='1697904736'></acronym>
      <center id='1697904736'><center id='1697904736'><tfoot id='1697904736'></tfoot></center><abbr id='1697904736'><dir id='1697904736'><tfoot id='1697904736'></tfoot><noframes id='1697904736'>

    • <optgroup id='1697904736'><strike id='1697904736'><sup id='1697904736'></sup></strike><code id='1697904736'></code></optgroup>
        1. <b id='1697904736'><label id='1697904736'><select id='1697904736'><dt id='1697904736'><span id='1697904736'></span></dt></select></label></b><u id='1697904736'></u>
          <i id='1697904736'><strike id='1697904736'><tt id='1697904736'><pre id='1697904736'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:9439
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Security flaws in third
          Security flaws in third

          AdobeInthelastyear,cyberattacksonhospitalshavesurged,puttingaspotlightontheneedtoprotectpatients’hea

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Harvard's David Sinclair gets blowback over aging

          DavidSinclairinhislabatHarvardMedicalSchool.CraigF.Walker/GlobeStaffRenownedHarvardUniversitygenetic